PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Pharma’s reputation has climbed during COVID-19 pandemic, study finds

A study from FutureBrand found that the perception of pharma and healthcare companies improved since the beginning of the COVID-19 pandemic. Using data collected d...
Continue Reading →
News

Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial

Novartis has revealed positive results from a phase 2 study of its CAR-T therapy Kymriah (tisagenlecleucel) in patients with relapsed or refractory follicular lympho...
Continue Reading →
News

CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched

2021 postponement will ensure positive business conditions and greater attendance Amsterdam, 27 July 2020: CPhI Japan – organised by Informa Markets – announces th...
Continue Reading →
News

People at high risk of diabetes fast-tracked into prevention programme

People at high risk of developing type II diabetes will be fast-tracked into the Healthier You NHS Diabetes Prevention programme, on the back of research indicating ...
Continue Reading →
News

Gov unveils new anti-obesity measures

The government has revealed a package of new measures falling under its new Obesity Strategy that are designed to improve health, ease the related burden on the NHS,...
Continue Reading →
News

Sobi to refile Gamifant following CHMP rejection

Sobi has announced its intent to file for a re-examination of Gamifant (emapalumab) in Europe following negative opinion by the European Medicines Agency's human med...
Continue Reading →
News

AZ’ Farxiga hits all goals in chronic kidney disease trial

AstraZeneca's Farxiga’s (dapagliflozin) has hit all primary and secondary endpoints in a late stage trial assessing its use in patients with chronic kidney disease (...
Continue Reading →
News

New research to investigate higher COVID-19 risk among BAME groups

Six new projects hoping to further improve understanding of the links between ethnicity and susceptibility to COVID-19 are being funded by the NIHR and UK Research a...
Continue Reading →
News

EC approves subcutaneous version of Remsima

The European Commission has authorised the world’s first subcutaneous formulation of infliximab, Remsima SC, for an additional five indications including for use in ...
Continue Reading →
News

UK launch for Ajovy injector pen

Teva UK has launched a pre-filled pen for Ajovy (fremanezumab) injection, offering patients with migraine a more convenient and flexible dosing option than with a sy...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026